SPYRE THERAPEUTICS, INC. (SYRE) Net margin 2016–2023
SPYRE THERAPEUTICS, INC. (SYRE) net profit margin by fiscal year — reported net income divided by reported revenue.
-38238.1%FY2023 · since FY2016: -468.8% → -38238.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -38238.1% | -34639.4 pp |
| FY2022 | -3598.8% | -3247.6 pp |
| FY2021 | -351.1% | — |
| FY2018 | -1140.6% | -617.4 pp |
| FY2017 | -523.3% | -54.4 pp |
| FY2016 | -468.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SYRE financial trends
SYRE RevenueSYRE Net incomeSYRE Gross profitSYRE Gross marginSYRE Operating incomeSYRE Operating marginSYRE Operating cash flowSYRE Free cash flowSYRE Capital expendituresSYRE Return on equitySYRE Stock buybacksSYRE Dividends paidSYRE Total assetsSYRE Total liabilitiesSYRE Shareholders’ equitySYRE overview →